Johnson & Johnson (JNJ) Financials
Johnson & Johnson (JNJ) Historical Financial Statements and Key Metrics for 1994 - 2025
Full Johnson & Johnson financials for 1994 - 2025 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Johnson & Johnson Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2025-Sep-28 | 23,993 | 16,690 (69.6 %) | 7,096 (29.6 %) | 5,152 (21.5 %) | 9,288 | 2.12 |
| 2025-Jun-29 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2025-Mar-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2024-Dec-29 | 22,520 | 15,392 (68.3 %) | 3,841 (17.1 %) | 3,431 (15.2 %) | 5,920 | 1.41 |
| 2024-Sep-29 | 22,471 | 15,508 (69.0 %) | 2,694 (12.0 %) | 2,694 (12.0 %) | 5,484 | 1.11 |
| 2024-Sep-28 | 22,471 | 15,688 (69.8 %) | 5,261 (23.4 %) | 2,694 (12.0 %) | 7,100 | 1.11 |
| 2024-Jun-30 | 22,447 | 15,578 (69.4 %) | 7,499 (33.4 %) | 4,686 (20.9 %) | 9,281 | 1.93 |
Full historical income statements for 1994 - 2025 is included in the
US Historical Financials dataset.
Johnson & Johnson Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2025-Sep-28 | 192,816 | 113,539 | 6,387 | 79,277 | 18,562 |
| 2025-Jun-29 | 193,389 | 114,916 | 50,761 | 78,473 | 18,880 |
| 2025-Mar-30 | 193,671 | 115,562 | 52,252 | 78,109 | 38,781 |
| 2024-Dec-29 | 180,104 | 108,614 | 36,634 | 71,490 | 24,522 |
| 2024-Sep-29 | 178,287 | 108,129 | 35,751 | 70,158 | 20,297 |
| 2024-Sep-28 | 0 | -71,538 | 0 | 71,538 | 25,475 |
| 2024-Jun-30 | 181,088 | 109,550 | 41,491 | 71,538 | 25,475 |
Full historical balance sheet data for 1994 - 2025 is included in the
US Historical Financials dataset.
Johnson & Johnson Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2025-Sep-28 | 9,169 | -542 | -8,927 | 8,381 |
| 2025-Jun-29 | 3,878 | -18,264 | -5,665 | 2,480 |
| 2025-Mar-30 | 4,174 | -297 | 10,422 | 3,365 |
| 2024-Dec-29 | 6,983 | -1,320 | -1,340 | 4,838 |
| 2024-Sep-29 | 7,993 | -3,128 | -9,882 | 5,714 |
| 2024-Sep-28 | 0 | 0 | 0 | 0 |
| 2024-Jun-30 | 5,633 | -13,687 | 7,544 | 4,657 |
Full historical cash flow data for 1994 - 2025 is included in the
US Historical Financials dataset.
Johnson & Johnson Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2025-Sep-28 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2025-Jun-29 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2025-Mar-30 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2024-Dec-29 | 345,008 | 357,537 | 15.32 | 25.14 | 4.83 |
| 2024-Sep-29 | 390,127 | 405,898 | 17.36 | 36.20 | 5.56 |
| 2024-Sep-28 | 393,466 | 393,466 | 17.51 | 36.51 | 5.50 |
| 2024-Jun-30 | 352,452 | 369,065 | 15.70 | 18.80 | 4.93 |
Full historical valuation and operating metrics for 1994 - 2025 are included in the
US Historical Financials dataset.